The Mucous Membrane Decontamination Market is expected to grow on an irreversible note in the next 10 years. The future scenario would be data-driven healthcare. This would, in turn, widen the potential for enhancing treatment options. With interoperability taking the centre stage, program participants could access app blueprints, data templates, and security tools. Thus, the big data cloud would turn out to be kinetic. This would result in an upswing in the healthcare vertical going forward.
According to the latest research by PMR, mucous membrane decontamination is set to witness a high-paced growth of CAGR 7.9% during the year 2021-2031.
The mucous membranes in the upper airways and the GI tracts possess a rich and variable flora of largely harmless bacteria. With the initial advent of the COVID-19 pandemic, the concern regarding safe practice with respect to administering a swab into the lower buccal cavity as well as nasal route initiated the increase in demand of mucous membrane decontamination.
Mucous membrane decontamination thus refers to as the maximum possible reduction of the physiological microbial mucous membrane flora, including pathogens colonising it. The demand for products for mucous membrane decontamination is an increasing trend with reference to infection prevention.
Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/32865
The products possess a limited spectrum of activity due to the sensitivity of the mucous membrane. The decontamination process is thus a combination with other antiseptic measures.
The demand for mucous membrane decontamination is increasing due to the growing incidences of wound related infections and the rising instances of surgical procedures globally.
According to a survey sponsored by the World Health Organization (2019), the prevalence of Hospital acquired infections or nosocomial infections accounts a range of 6-24%, among which, over 34% accounts for wound related infections or surgical site infections.
The growing awareness in terms of infection prevention and control have led to drive the demand for mucous membrane decontamination measures. Furthermore, the advancements in over-the-counter mucous membrane decontamination products have led to a rise in the adoption of disinfection and treatment of both wounds as well as the mucous membrane.
The looming threat of infectious diseases and an increase in the prevalence of population affected by it will act as a major augmentative factor for growth of mucous membrane decontamination.
Subsequently, in regards to the rising geriatric population over the globe, the increasing number of surgical and transplantation procedures is set to boost the demand of mucous membrane decontamination.
Request for Table of Content@ https://www.persistencemarketresearch.com/toc/32865
The region of North America is expected to grow at a significant rate over the forecast period.
This is propelled by the increasing number of surgical procedures in the region. According to 2018 data, each year in the U.S., there are approximately 53 million outpatient surgical procedures and 46 million inpatient surgical procedures.
As per the public health information published in Elsevier, “A number of outbreaks and infections were reported in the hospital setup because of improperly sterilized devices. Many infections were reported throughout the world due to use of contaminated endoscopes”. These are the key indicators for rising adoption of mucous membrane decontamination systems in the region.
The region of Europe is anticipated to occupy a large share in the adoption of mucous membrane decontamination after North America. The stance is observed through the emergence of key market players in the region. The products include disinfectants and cleaners for equipment, surgical site, instruments and the mucosal membrane of the body.
One such example of key player includes Mölnlycke Health Care AB, which provides the Granudacyn® range of products for management of infections and mucous membrane decontamination.
The key companies operating in manufacturing and supply of mucous membrane decontamination are,
- Mölnlycke Health Care AB
- Ecolab
- Schülke & Mayr (Asia) Pte. Ltd.
- 3M
- Purell
- Reckitt Benckiser
- Beijing Xidebao
- BODE Chemie
- Saraya.
Access Full Report@ https://www.persistencemarketresearch.com/checkout/32865
Key Segments:
By Product Type
- Alcohol Based
- Non-Alcohol Based
By End-User
- Medical Hospitals
- Ambulatory Surgical Centers
- Home-Care Settings
- Households
- Clinics
- Others
About Us: Persistence Market Research
Contact Us:
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com